NONSENSE RNA SURVEILLANCE IN HEALTH AND DISEASE
NONSENSE RNA SURVEILLANCE IN HEALTH AND DISEASE
批准号:
6138543
负责人:
Harry C., III Dietz
金额:
$11.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-07 至 2001-12-31
关键词:
RNA RNA splicing RNase protection assay antisense nucleic acid embryonic stem cell gene complementation gene expression gene targeting genetic translation in situ hybridization laboratory mouse molecular cloning northern blottings nucleic acid sequence phenotype polymerase chain reaction protein structure function restriction mapping transcription factor transfection translation factor
中文摘要
描述(改编自应用):所有生物从真细菌到
真核生物具有降解含有一种
提前终止密码子。无义介导的RNA衰变过程
(NMRD)在酵母中研究得最好,但在某些方面
NMRD在哺乳动物中似乎有很大的不同。特别是,作为博士。
Dietz发现了(其他人随后也证实了)过早的胡说八道
密码子可以改变核转录因子的剪接模式。一个吸引人的想法是
NMRD演变为一种监视机制,以保护细胞免受有害物质的伤害
截短蛋白的影响;酵母和哺乳动物之间的差异可能
然后反映哺乳动物内含子的丰富和内含子的匮乏
放在酵母里。Dietz博士已经为这一点获得了很好的证据
马凡综合征,其中羧基末端截短纤维蛋白(FBN1)
干扰细胞外基质的组织。这个机制是通过
哪种剪接(可能是核过程)会受到翻译的影响
(可能是细胞质过程)是一个谜,许多模型都是
被引用来探索这一观察。也许关键的问题是关于
NMRD是指核糖体或其他某种装置是否对
扫描ORF;抑制子tRNA部分抑制的能力
NMRD主张发挥核糖体的作用,但奇怪的事情已经发生了。三
被称为UPF1、2和3的酵母蛋白(代表上移码)已经被
基因上被认为是NMRD的必需品;Dietz博士现在克隆了
UPF1的人类同源物,并命名为RENT1(用于无稽之谈的调节
文字记录)。此应用程序旨在探索以下三个方面
RENT1功能:(1)RENT1在小鼠中表达的地点、时间和方式;
以及假定的RENT1的显性负突变(以已知
酵母UPF1p中的显性负值)通过稳定报告结构
无意义突变?(2)小鼠RENT1基因敲除的表型是什么?
NMRD在整个动物体内的缺失是否会影响各种基因的表达
天然的还是人造的mRNA?作为内部控制,以监控
NMRD,Dietz博士将使用一种被称为Gusmps的自发移码突变
这会导致小鼠β-葡萄糖醛酸酶mRNA水平下降200倍。
与R11X无义突变相似的小鼠对照
4-羟基苯丙酮酸双加氧酶基因也被提出。(3)在
组织培养或小鼠模型可通过RENT1下调NMRD的表达
显性负性抢救由过早的废话引起的疾病表型
密码子,甚至被用来检测新的疾病基因?D836X胡说八道
囊性纤维化跨膜中的突变(或类似突变)
电导通道)将提供一个治疗上重要的测试案例
监督这种方法的成功。此外,使用等基因
表达或不表达显性负RENT1等位基因的成纤维细胞系,
Dietz博士将尝试通过RDA(表征差异)来重新建立
分析)无意义的密码子是导致燕麦缺陷的原因
回旋性萎缩患者。
英文摘要
DESCRIPTION (adapted from application): All organisms from eubacteria to
eukaryotes have mechanisms for degrading transcripts that contain a
premature termination codon. The process of nonsense-mediated RNA decay
(NMRD) has been best studied in the yeast S. cerevisiae, but some aspects of
NMRD appear to be significantly different in mammals. In particular, as Dr.
Dietz discovered (and others have subsequently confirmed) premature nonsense
codons can alter nuclear mRNA splicing patterns. An attractive idea is that
NMRD evolved as a surveillance mechanism to protect cells from the harmful
effects of truncated proteins; differences between yeast and mammals might
then reflect the abundance of introns in mammals and the paucity of introns
in yeast. Dr. Dietz has obtained good evidence for this in the case of
Marfan's syndrome, where carboxyterminal truncated fibrillin protein (FBN1)
interferes with organization of the extracellular matrix. The mechanism by
which splicing (presumably a nuclear process) can be affected by translation
(presumably a cytoplasmic process) is a mystery, and many models have been
invoked to explore this observation. Perhaps the key question regarding
NMRD is whether the ribosome or some other device is responsible for
scanning the ORFs; the ability of a suppressor tRNA to partially suppress
NMRD argues for a ribosomal role, but stranger things have happened. Three
yeast proteins called UPF1, 2, and 3 (for up-frameshift) have been
identified genetically as essential for NMRD; Dr. Dietz has now cloned the
human homologue of UPF1, and named it RENT1 (for regulation of nonsense
transcripts). This application is designed to explore three aspects of
RENT1 function: (1) Where, when, and how is RENT1 expressed in the mouse,
and will putative dominant negative mutants of RENT1 (modeled on known
dominant negatives in yeast UPF1p) stabilize reporter constructs with
nonsense mutations? (2) What is the phenotype of a mouse RENT1 knockout,
and does loss of NMRD in the whole animal affect expression of various
natural or artificial mRNAs? As an internal control to monitor levels of
NMRD, Dr. Dietz will use a spontaneous frameshift mutation known as gusmps
which causes a 200-fold decrease in murine beta-glucuronidase mRNA levels.
Similar controls with the R11X nonsense mutation in the murine
4-hydroxyphenylpyruvic acid dioxygenase gene are also proposed. (3) In a
tissue culture or mouse model, can down regulation of NMRD by a RENT1
dominant negative rescue a disease phenotype caused by a premature nonsense
codon, or even be used to detect new disease genes? The D836X nonsense
mutation (or similar mutations) in the CFTR (cystic fibrosis transmembrane
conductance channel) will provide a therapeutically important test case to
monitor the success of this approach. In addition, using isogenic
fibroblast lines that do or do not express a dominant negative RENT1 allele,
Dr. Dietz will attempt to "reestablish" by RDA (representational difference
analysis) that a nonsense codon is responsible for the OAT defect in a
gyrate atrophy patient.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Mechanistic and Therapeutic Investigations of Scleroderma
-
批准号:9304862
-
项目类别:
-
资助金额:$35.97万
-
财政年份:2016
-
负责人:Harry C., III Dietz
-
依托单位:
Systems Biology and Connective Tissue Disorders
-
批准号:8063338
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2010
-
负责人:Harry C., III Dietz
-
依托单位:
Novel Biomarkers in Aortic Aneurysms and Acute Aortic Dissection
-
批准号:7935405
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2009
-
负责人:Harry C., III Dietz
-
依托单位:
Novel Biomarkers in Aortic Aneurysms and Acute Aortic Dissection
-
批准号:7815944
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Harry C., III Dietz
-
依托单位:
Molecular Biology of Marfan Syndrome
-
批准号:7931831
-
项目类别:
-
资助金额:$28.31万
-
财政年份:2009
-
负责人:Harry C., III Dietz
-
依托单位:
Exploration of Therapeutic Strategies in Mar
-
批准号:7460912
-
项目类别:
-
资助金额:$24.22万
-
财政年份:2007
-
负责人:Harry C., III Dietz
-
依托单位:
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication
-
批准号:8317953
-
项目类别:
-
资助金额:$50.79万
-
财政年份:2004
-
负责人:Harry C., III Dietz
-
依托单位:
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication
-
批准号:7779664
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2004
-
负责人:Harry C., III Dietz
-
依托单位:
PROJECT 4: Exploration of Therapeutic Strategies in Mar
-
批准号:6852076
-
项目类别:
-
资助金额:$24.46万
-
财政年份:2004
-
负责人:Harry C., III Dietz
-
依托单位:
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication
-
批准号:8527712
-
项目类别:
-
资助金额:$46.55万
-
财政年份:2004
-
负责人:Harry C., III Dietz
-
依托单位:
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication
-
批准号:8122262
-
项目类别:
-
资助金额:$44.03万
-
财政年份:2004
-
负责人:Harry C., III Dietz
-
依托单位:
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication
-
批准号:8379269
-
项目类别:
-
资助金额:$48.31万
-
财政年份:2004
-
负责人:Harry C., III Dietz
-
依托单位:
NONSENSE RNA SURVEILLANCE IN HEALTH AND DISEASE
-
批准号:2634826
-
项目类别:
-
资助金额:$11.02万
-
财政年份:1997
-
负责人:Harry C., III Dietz
-
依托单位:
NONSENSE RNA SURVEILLANCE IN HEALTH AND DISEASE
-
批准号:2857267
-
项目类别:
-
资助金额:$11.27万
-
财政年份:1997
-
负责人:Harry C., III Dietz
-
依托单位:
NONSENSE RNA SURVEILLANCE IN HEALTH AND DISEASE
-
批准号:2023810
-
项目类别:
-
资助金额:$16.54万
-
财政年份:1997
-
负责人:Harry C., III Dietz
-
依托单位:
Molecular Biology of Marfan Syndrome
-
批准号:7922910
-
项目类别:
-
资助金额:$4.1万
-
财政年份:1992
-
负责人:Harry C., III Dietz
-
依托单位:
MOLECULAR BIOLOGY OF THE MARFAN SYNDROME
-
批准号:6732613
-
项目类别:
-
资助金额:$22.7万
-
财政年份:1992
-
负责人:Harry C., III Dietz
-
依托单位:
Molecular Biology of Marfan Syndrome
-
批准号:7574473
-
项目类别:
-
资助金额:$34.33万
-
财政年份:1992
-
负责人:Harry C., III Dietz
-
依托单位:
Molecular Biology of Marfan Syndrome
-
批准号:7758192
-
项目类别:
-
资助金额:$42.15万
-
财政年份:1992
-
负责人:Harry C., III Dietz
-
依托单位:
DEVELOPMENT OF A TRANSGENIC MODEL OF THE MARFAN SYNDROME
-
批准号:2210615
-
项目类别:
-
资助金额:$8.61万
-
财政年份:1992
-
负责人:Harry C., III Dietz
-
依托单位:
海外基金